Oligonucleotide Synthesis Market - Research Report 2023
North America held the largest share in oligonucleotide synthesis, with 39.1% contribution in 2017. This can be attributed to technological advancements, favorable government regulations, and high incidence of infectious diseases in the region.
North America held the largest share in oligonucleotide synthesis, with 39.1% contribution in 2017. This can be attributed to technological advancements, favorable government regulations, and high incidence of infectious diseases in the region.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Oligonucleotide</strong> <strong>Synthesis</strong><br />
<strong>Market</strong> to Reach $2.8 Billion by <strong>2023</strong><br />
www.psmarketresearch.com
<strong>Oligonucleotide</strong> <strong>Synthesis</strong> <strong>Market</strong><br />
Global oligonucleotide synthesis market is expected to reach $2.8 billion by <strong>2023</strong>, the market is<br />
mainly driven by advancements in oligonucleotide synthesis technologies, favorable government<br />
regulations, growing research activities in synthetic biology, and rising prevalence of cancer and<br />
infectious diseases<br />
Explore report at: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesismarket<br />
Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides,<br />
reagents and consumables, and equipment. During the historical period, synthesized oligonucleotides<br />
held the largest share in the market, accounting for 76.3% in 2017.<br />
“<br />
Copyright © P&S <strong>Market</strong> <strong>Research</strong>
<strong>Oligonucleotide</strong> <strong>Synthesis</strong> <strong>Market</strong><br />
Based on application, the oligonucleotide synthesis market is categorized into research,<br />
diagnostics, and therapeutics. Of these, the fastest growth in the market during the forecast<br />
period is expected from research applications, with a CAGR of 11.1%.<br />
On the basis of end user, the market is categorized into academic research institutes, diagnostic<br />
laboratories, pharmaceutical and biotechnology companies, and others. Others primarily include<br />
food and beverage companies and forensic laboratories. Academic research institutes are<br />
expected to continue holding the largest share in the oligonucleotide synthesis market in the<br />
coming years. They accounted for 40.4% share in the market in 2017.<br />
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiryurl=oligonucleotide-synthesis-market<br />
Copyright © P&S <strong>Market</strong> <strong>Research</strong>
<strong>Oligonucleotide</strong> <strong>Synthesis</strong> <strong>Market</strong><br />
In order to increase their market share, key players of the oligonucleotide synthesis industry are<br />
seeking partnerships and acquisitions. For instance, in May 2018, LGC Biosearch Technologies Inc.<br />
(LGC) acquired BioAutomation Corporation (BioAutomation), a manufacturer of MerMade oligo<br />
synthesis instruments. The acquisition followed LGC’s acquisitions of Biosearch, Prime <strong>Synthesis</strong>,<br />
and LINK Technologies, and is expected to further drive the company’s growth in the<br />
oligonucleotide reagent and synthesized oligonucleotide markets.<br />
Request for report sample at: https://www.psmarketresearch.com/marketanalysis/oligonucleotide-synthesis-market/report-sample<br />
In March 2018, Thermo Fisher Scientific Inc. (Thermo Fisher), acquired IntegenX Inc., a provider of<br />
rapid DNA platforms for use in forensics and law enforcement applications. IntegenX products<br />
have significantly enhanced Thermo Fisher's existing human identification (HID) portfolio and<br />
complemented its leading human identification chemistries, and qPCR and capillary<br />
electrophoresis systems.<br />
Copyright © P&S <strong>Market</strong> <strong>Research</strong>
<strong>Oligonucleotide</strong> <strong>Synthesis</strong> <strong>Market</strong><br />
Some of the other key players operating in the oligonucleotide synthesis industry are General Electric<br />
Company, Merck KGaA, Eurofins Scientific SE, Integrated DNA Technologies Inc., GeneDesign Inc., Trilink<br />
Biotechnologies LLC, Nitto Denko Avecia Inc., and Kaneka Eurogentec S.A.<br />
Copyright © P&S <strong>Market</strong> <strong>Research</strong>
THANK YOU!<br />
Click to edit Master title style<br />
For queries, kindly write to:<br />
Edit Master text styles<br />
GET IN TOUCH<br />
enquiry@psmarketresearch.com<br />
www.psmarketresearch.com<br />
US/Canada Toll-Free: 1-888-778-7886<br />
2/7/2019 6<br />
B-13, Sector-2, Noida, U.P.-201301, INDIA<br />
Contact No: +91 120 4541 337<br />
US/Canada Toll-Free: 1-888-778-7886
Change language